Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low CD34 cell dose is associated with higher non-relapse and overall mortality after reduced intensity conditioning hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Meeting Abstract

    Thörlén, J.; Ringdén, O.; Le Rademacher, J.; Battiwalla, M.; Chen, J.; Ho, V. T.; Kebriaei, P.; Keever-Taylor, C. A.; Kindwall-Keller, T. L.; Lazarus, H. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Microenvironment assessment, disease characteristics and prognosis In HIV-associated (HIV-cHL) and HIV-negative classical Hodgkin lymphoma: The influence of Epstein Barr virus (EBV)
    Meeting Abstract

    Rubinstein, P. G.; Sreenivasappa, S.; Messinger, M.; Petrich, A. M.; Moreira, J.; Bryan, L. J.; Angelova, V.; Gupta, S.; Noy, A.; Sumpter, I.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Next-generation sequencing suggests complex, heterogeneous pathogenesis in peripheral T-cell lymphoma unspecified
    Meeting Abstract

    Schatz, J. H.; Horwitz, S. M.; Lunning, M. A.; Dolgalev, I.; Huberman, K.; Heguy, A.; Viale, A.; Socci, N. D.; Pirun, M.; Teruya-Feldstein, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Higher stem cell dose infusion as rescue after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis
    Meeting Abstract

    Shah, N.; Williams, L. A.; Worthing, A.; Shi, Q.; Wang, X. S.; Johnson, V.; Mendoza, T. R.; Qazilbash, M. H.; Champlin, R. E.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin
    Meeting Abstract

    Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Epigenetic profiling of leukemia stem cells in a model of TET2/FLT3-mutant AML
    Meeting Abstract

    Shih, A. H.; Jiang, Y.; Shank, K.; Pandey, S.; Viale, A.; Sun, Y.; Socci, N.; Robertson, A.; de Stanchina, E.; Hricik, T.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II trial of bortezomib in combination with fractionated cyclophosphamide and rituximab (BCR) for relapsed/refractory mantle cell lymphoma (MCL)
    Meeting Abstract

    Romaguera, J. E.; Fanale, M. A.; Samaniego, F.; Fayad, L. E.; Hagemeister, F. B.; McLaughlin, P.; Rodriguez, M. A.; Weaver, P.; Hartig, K.; Badillo, M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Azacitidine with or without entinostat for the treatment of therapy-related myeloid neoplasm: Further results of the E1905 North American Leukemia Intergroup Study
    Meeting Abstract

    Prebet, T.; Sun, Z.; Ketterling, R.; Greenberg, P. L.; Zeidan, A. M.; Litzow, M. R.; Gabrilove, J. L.; Erba, H. P.; Paietta, E.; Czader, M.; more...
    Blood (2013)

    Fulltext@MSK | Save